<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/stylesheet.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link rel="self" type="application/atom+xml" href="https://feeds.transistor.fm/managing-your-glucotype-and-cgp" title="MP3 Audio"/>
    <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/"/>
    <podcast:podping usesPodping="true"/>
    <title>Continuous Glucose Monitoring (CGM): stories, tips and tricks </title>
    <generator>Transistor (https://transistor.fm)</generator>
    <itunes:new-feed-url>https://feeds.transistor.fm/managing-your-glucotype-and-cgp</itunes:new-feed-url>
    <description>This article is written for patients who have tried a CGM and found  significant glucose dysregulation.</description>
    <copyright>© 2025 Dr Edward Leatham</copyright>
    <podcast:guid>76d7ce61-1f60-5467-881c-fdfd92059d26</podcast:guid>
    <podcast:locked owner="reception@scvc.co.uk">no</podcast:locked>
    <language>en</language>
    <pubDate>Sun, 20 Oct 2024 17:47:11 +0100</pubDate>
    <lastBuildDate>Wed, 03 Dec 2025 05:04:20 +0000</lastBuildDate>
    <link>https://www.scvc.co.uk/metabolic-health/glucotype-iii-b/</link>
    <image>
      <url>https://img.transistor.fm/3nO0VE11-s0XActAei6z_oTTfuGHu5TGrBXQhbVheEk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lY2I1/YmU0YjlhMDg5OTE3/YWRiNDQyNmExNDRi/NzMyOS5wbmc.jpg</url>
      <title>Continuous Glucose Monitoring (CGM): stories, tips and tricks </title>
      <link>https://www.scvc.co.uk/metabolic-health/glucotype-iii-b/</link>
    </image>
    <itunes:category text="Health &amp; Fitness"/>
    <itunes:type>episodic</itunes:type>
    <itunes:author>Dr Edward Leatham</itunes:author>
    <itunes:image href="https://img.transistor.fm/3nO0VE11-s0XActAei6z_oTTfuGHu5TGrBXQhbVheEk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lY2I1/YmU0YjlhMDg5OTE3/YWRiNDQyNmExNDRi/NzMyOS5wbmc.jpg"/>
    <itunes:summary>This article is written for patients who have tried a CGM and found  significant glucose dysregulation.</itunes:summary>
    <itunes:subtitle>This article is written for patients who have tried a CGM and found  significant glucose dysregulation..</itunes:subtitle>
    <itunes:keywords>CGM, Glucose, Glucotype</itunes:keywords>
    <itunes:owner>
      <itunes:name>SCVC</itunes:name>
    </itunes:owner>
    <itunes:complete>No</itunes:complete>
    <itunes:explicit>No</itunes:explicit>
    <item>
      <title>Personalised nutrition advice guide by CGM: is the future now here?</title>
      <itunes:episode>4</itunes:episode>
      <podcast:episode>4</podcast:episode>
      <itunes:title>Personalised nutrition advice guide by CGM: is the future now here?</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">5211b468-7089-4c2b-a10e-cf81c30654fa</guid>
      <link>https://share.transistor.fm/s/c42797d4</link>
      <description>
        <![CDATA[<p>Insights gained from the use of continuous glucose monitors (CGM) have revealed that many non-diabetic individuals exhibit transient spikes in blood glucose after consuming high-carbohydrate foods to levels normally only seen in insulin resistant or deficient diabetics. This observation has sparked significant interest in whether ‘glucose dysregulation’, characterised by both high variability (a known cardiovascular risk factor) and excursions (‘spikes’) above normal levels (e.g., 7.8 mmol/L or 140 mg/dL), could be actually causing many long-term diseases.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Insights gained from the use of continuous glucose monitors (CGM) have revealed that many non-diabetic individuals exhibit transient spikes in blood glucose after consuming high-carbohydrate foods to levels normally only seen in insulin resistant or deficient diabetics. This observation has sparked significant interest in whether ‘glucose dysregulation’, characterised by both high variability (a known cardiovascular risk factor) and excursions (‘spikes’) above normal levels (e.g., 7.8 mmol/L or 140 mg/dL), could be actually causing many long-term diseases.</p>]]>
      </content:encoded>
      <pubDate>Sun, 20 Oct 2024 17:47:03 +0100</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/c42797d4/42c65d2d.mp3" length="13829940" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:duration>862</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Insights gained from the use of continuous glucose monitors (CGM) have revealed that many non-diabetic individuals exhibit transient spikes in blood glucose after consuming high-carbohydrate foods to levels normally only seen in insulin resistant or deficient diabetics. This observation has sparked significant interest in whether ‘glucose dysregulation’, characterised by both high variability (a known cardiovascular risk factor) and excursions (‘spikes’) above normal levels (e.g., 7.8 mmol/L or 140 mg/dL), could be actually causing many long-term diseases.</p>]]>
      </itunes:summary>
      <itunes:keywords>CGM, Glucose, Glucotype</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Glucose: A Matter of Life and Death</title>
      <itunes:episode>3</itunes:episode>
      <podcast:episode>3</podcast:episode>
      <itunes:title>Glucose: A Matter of Life and Death</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">17583728-e3ed-4db2-86de-789f9f727e73</guid>
      <link>https://share.transistor.fm/s/81e4e401</link>
      <description>
        <![CDATA[<p>There is increasing evidence that high blood and tissue glucose levels may be an important risk factor for many non communicable diseases.</p><p>CGM monitoring should be considered in all patients affected by heart disease, in order to define glucotype and current glucose profile- both easily treated if 'unhealthy' .</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>There is increasing evidence that high blood and tissue glucose levels may be an important risk factor for many non communicable diseases.</p><p>CGM monitoring should be considered in all patients affected by heart disease, in order to define glucotype and current glucose profile- both easily treated if 'unhealthy' .</p>]]>
      </content:encoded>
      <pubDate>Sun, 20 Oct 2024 11:42:09 +0100</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/81e4e401/a52370ac.mp3" length="8366692" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistor.fm/TT1s5Vsb_YGCMX-12SLWfFLfxA5XGkiSMRuUSbUP8EQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jNmY0/MDAzNmY0ZDZhNGFh/MmYxN2UyNTI2OGE0/ZTllNC5qcGc.jpg"/>
      <itunes:duration>519</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>There is increasing evidence that high blood and tissue glucose levels may be an important risk factor for many non communicable diseases.</p><p>CGM monitoring should be considered in all patients affected by heart disease, in order to define glucotype and current glucose profile- both easily treated if 'unhealthy' .</p>]]>
      </itunes:summary>
      <itunes:keywords>CGM, Glucose, Glucotype</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Why personalised wellness starts with a CGM: what is CGP IIIC all about?</title>
      <itunes:episode>2</itunes:episode>
      <podcast:episode>2</podcast:episode>
      <itunes:title>Why personalised wellness starts with a CGM: what is CGP IIIC all about?</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">323d29bf-12e3-40d2-ab28-ed0bc40f4bee</guid>
      <link>https://share.transistor.fm/s/9ab8a41f</link>
      <description>
        <![CDATA[<p>This article is written for patients with an unhealthy (high) BMI who have undergone a metabolic health assessment where either their personalised CGP is found to be <strong>IIIC</strong>, meaning there is moderate glucose dysregulation. There may be an ambition to lower central fat stores, waistline and body weight.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>This article is written for patients with an unhealthy (high) BMI who have undergone a metabolic health assessment where either their personalised CGP is found to be <strong>IIIC</strong>, meaning there is moderate glucose dysregulation. There may be an ambition to lower central fat stores, waistline and body weight.</p>]]>
      </content:encoded>
      <pubDate>Sat, 19 Oct 2024 10:11:16 +0100</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/9ab8a41f/88796af1.mp3" length="5706883" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:duration>354</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>This article is written for patients with an unhealthy (high) BMI who have undergone a metabolic health assessment where either their personalised CGP is found to be <strong>IIIC</strong>, meaning there is moderate glucose dysregulation. There may be an ambition to lower central fat stores, waistline and body weight.</p>]]>
      </itunes:summary>
      <itunes:keywords>CGM, Glucose, Glucotype</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Type IIIB CGP: why it may be important to know your CGP, even if you are not overweight.</title>
      <itunes:episode>1</itunes:episode>
      <podcast:episode>1</podcast:episode>
      <itunes:title>Type IIIB CGP: why it may be important to know your CGP, even if you are not overweight.</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">631e59c2-6221-4b64-9ce7-33550d868aaa</guid>
      <link>https://share.transistor.fm/s/ca6e944d</link>
      <description>
        <![CDATA[<p>In many non diabetic patients wearing a CGM we observe frequent glucose excursions over 7.8 mmol/L (140 mg/dL) often averaging more than two per day, and even some exceeding 10 mmol/L. This suggests that there are some challenges in the body’s processing of carbohydrates. Although these individuals are not formally classified as ‘diabetic’ or ‘prediabetic’ by current standards, research indicates that this degree of glucose dysregulation may increase the risk of developing Type 2 diabetes and, over time, glucose spikes may contribute to an increase in inflammation in key organs such as the heart and brain. Therefore, it makes sense to implement lifestyle and dietary changes to improve glucose control.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In many non diabetic patients wearing a CGM we observe frequent glucose excursions over 7.8 mmol/L (140 mg/dL) often averaging more than two per day, and even some exceeding 10 mmol/L. This suggests that there are some challenges in the body’s processing of carbohydrates. Although these individuals are not formally classified as ‘diabetic’ or ‘prediabetic’ by current standards, research indicates that this degree of glucose dysregulation may increase the risk of developing Type 2 diabetes and, over time, glucose spikes may contribute to an increase in inflammation in key organs such as the heart and brain. Therefore, it makes sense to implement lifestyle and dietary changes to improve glucose control.</p>]]>
      </content:encoded>
      <pubDate>Fri, 18 Oct 2024 20:11:33 +0100</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/ca6e944d/0fb1bca2.mp3" length="7820917" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:duration>486</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In many non diabetic patients wearing a CGM we observe frequent glucose excursions over 7.8 mmol/L (140 mg/dL) often averaging more than two per day, and even some exceeding 10 mmol/L. This suggests that there are some challenges in the body’s processing of carbohydrates. Although these individuals are not formally classified as ‘diabetic’ or ‘prediabetic’ by current standards, research indicates that this degree of glucose dysregulation may increase the risk of developing Type 2 diabetes and, over time, glucose spikes may contribute to an increase in inflammation in key organs such as the heart and brain. Therefore, it makes sense to implement lifestyle and dietary changes to improve glucose control.</p>]]>
      </itunes:summary>
      <itunes:keywords>CGM, Glucose, Glucotype</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
  </channel>
</rss>
